| | Webinar: New Trends in Virtual Trials Monday, July 26 | 11am ET / 8am PT Last year, clinical trial platform developer Medable raised $91M in private funding, amid the COVID-19 pandemic that touched off huge demand among pharma companies looking to initiate “siteless” or virtual clinical trials. Explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now. |
153 Houston Methodist employees have resigned or were fired for refusing COVID-19 vaccination NIH antibody study uncovers millions of hidden, uncounted COVID-19 cases COVID-19 tracker: CDC panel finds link between mRNA vaccines and heart inflammation cases; Congress expands Emergent probe COVID-fighting llamas inspire 'nanobody' treatments to tackle emerging variants To debunk COVID-19 vaccine myths, health officials should turn to the same source that spreads them—social media AHA makes last-ditch effort to get HHS to extend COVID relief fund deadline Biden officials aim for the stars with new NIH research arm to push bold, risky biomedical ideas Featured Story | By Dave Muoio The former employees were among 178 suspended by Houston Methodist earlier this month for refusing to comply with its mandatory COVID-19 vaccination policy. A lawsuit brought against the system contesting the policy was recently tossed by a federal judge. read more |
| |
|---|
|
Top Stories By Conor Hale During the first six months of the COVID-19 pandemic, the spread of the coronavirus reached far further than initially known—with the official count potentially missing the mark by tens of millions of cases, according to a new antibody study conducted by the NIH. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner A CDC advisory panel has established a likely link between mRNA vaccines and rare cases of heart inflammation. The U.S. has expanded its investigation of an error-prone Emergent factory, asking AstraZeneca and Johnson & Johnson for all communications related to the contractor. And more headlines. read more By Arlene Weintraub Scientists led by Ohio State University identified two types of nanobodies that could bypass mutations and prevent the virus that causes COVID-19 from entering cells. The nanobodies, inspired by tiny antibodies made by llamas, were able to neutralize the alpha, beta and gamma variants of the virus, the researchers reported. read more By Heather Landi In their efforts to debunk vaccine myths, doctors are trying to combat a deluge of misinformation and false stories rampantly spreading on social media platforms like Facebook. Social media is the battlefield right now for vaccine trust efforts, one public official said. read more By Robert King AHA is making a last-ditch effort to persuade HHS to extend a June 30 deadline for some providers to spend all of their COVID-19 relief funds. read more By Annalee Armstrong President Biden has proposed a new research agency to sit within the National Institutes of Health, called the Advanced Research Projects Agency for Health. The program has requested an initial $6.5 billion in funding “to develop breakthroughs—to prevent, detect, and treat diseases like Alzheimer’s, diabetes, and cancer,” according to a paper by several officials published Tuesday. read more | | Webinar: COVID-19 Virus Sequencing for Drug Development Wednesday, July 28 | 10:30am ET / 7:30am PT As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now. |
|
